Zessly

Zessly is an anti-inflammatory medicine for treating the following diseases: - rheumatoid arthritis (disease causing inflammation of the joints); - Crohn’s disease (disease causing inflammation of the gut); - ulcerative colitis (inflammation and ulcers in the lining of the gut); - ankylosing spondylitis (inflammation of spine causing back pain); - psoriasis (red, scaly patches on the skin); - psoriatic arthritis (psoriasis with inflammation of the joints). Zessly is used mainly in adults, usually when other medicines or treatments have failed or cannot be used. For Crohn’s disease and ulcerative colitis, it is also used in children from 6 years of age. For some conditions, Zessly is also used in combination with another medicine, methotrexate. Zessly is a ‘biosimilar medicine’. This means that it is highly similar to another biological medicine (the ‘reference medicine’) that is already authorised in the EU. The reference medicine for Zessly is Remicade. For more information on biosimilar medicines, see 'Related content' below.